Related Experiment Videos
Combining CNS transplantation and gene transfer.
1Massachusetts General Hospital, Charlestown.
Neurobiology of Aging
|September 1, 1989
Summary
Genetic modification of brain grafts enhances neuroactive substance delivery. Genetically engineered cells delivering nerve growth factor (NGF) support the survival of specific neurons in the central nervous system (CNS).
Area of Science:
- Neuroscience
- Regenerative Medicine
- Gene Therapy
Background:
- Brain grafting is a potential method for delivering therapeutic substances to the central nervous system (CNS).
- Genetic modification offers a way to enhance the capabilities of grafted cells for targeted delivery.
Purpose of the Study:
- To investigate the potential of genetically modified brain grafts for enhanced delivery of neuroactive substances.
- To demonstrate the efficacy of engineered cells in supporting neuronal survival.
Main Methods:
- Cultured cells were genetically modified using retroviral vectors to express nerve growth factor (NGF).
- These modified cells were grafted into the CNS.
Main Results:
- The genetically modified grafts successfully delivered NGF within the CNS.
- NGF delivery mediated the survival of specific cholinergic neurons, demonstrating NGF-dependent survival.
Conclusions:
- Genetic modification significantly enhances the therapeutic applications of brain grafting.
- Engineered cells secreting neurotrophic factors like NGF represent a promising strategy for treating neurological conditions affecting neuronal survival.